Bionor Pharma ASA: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
Provider: Wright Reports
Bionor Pharma ASA Appoints Dr. Anker Lundemose New President and Chief Executive Officer
Bionor Pharma ASA announced that Dr. Anker Lundemose has been appointed new President and Chief Executive Officer (CEO) of Bionor Pharma ASA from March 1, 2013. Dr. Lundemose replaces Mr. Steen Kroyer, who has held the position of Interim CEO of the Company since September 2011, and who will take the position of Deputy Chairman of the Board of Directors in accordance with the nomination and election at the Company's Annual General Meeting of May 11, 2012.
Latest Developments for Bionor Pharma ASA
- Bionor Pharma ASA Completes Private Placement and Proposes Repair Offer
- Bionor Pharma ASA Announces Private Placement
- Bionor Pharma ASA Announces Successful Completion of First Part of Phase II Clinical Study Combining the HIV Vaccine Vacc-4x with Celgene's Immunomodulator Lenalidomide (Revlimid)
- Bionor Pharma ASA's Chief Executive Officer to Resign
- Share this
- Digg this